Detalles de la búsqueda
1.
Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.
PLoS Med
; 21(5): e1004389, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38728364
2.
Synergistic effects of Smac mimetic APG-1387 with anti-PD-1 antibody are attributed to increased CD3 + NK1.1 + cell recruitment secondary to induction of cytokines from tumor cells.
Cancer Cell Int
; 24(1): 181, 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38790057
3.
An evaluation model of hepatic steatosis based on CT value and serum uric acid/HDL cholesterol ratio can predict intrahepatic recurrence of colorectal cancer liver metastasis.
Int J Clin Oncol
; 2024 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38839664
4.
Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial.
Ann Surg
; 277(4): 557-564, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36538627
5.
Lymphovascular invasion represents a superior prognostic and predictive pathological factor of the duration of adjuvant chemotherapy for stage III colon cancer patients.
BMC Cancer
; 23(1): 3, 2023 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36593480
6.
Unveiling the Research Landscape and Emerging Trends in Cell Cycle for Cancer Immunotherapy: A Bibliometric Analysis (1990-2022).
Med Sci Monit
; 29: e940556, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38037303
7.
Primary tumor location affects recurrence-free survival for patients with colorectal liver metastases after hepatectomy: a propensity score matching analysis.
World J Surg Oncol
; 18(1): 98, 2020 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32423450
8.
The Immunoscore system predicts prognosis after liver metastasectomy in colorectal cancer liver metastases.
Cancer Immunol Immunother
; 67(3): 435-444, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29204700
9.
Oncogene mutation profile predicts tumor regression and survival in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and radical surgery.
Tumour Biol
; 39(7): 1010428317709638, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28671043
10.
Primary tumor location as a predictor of the benefit of palliative resection for colorectal cancer with unresectable metastasis.
World J Surg Oncol
; 15(1): 138, 2017 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28750680
11.
Surgery with versus without preoperative concurrent chemoradiotherapy for mid/low rectal cancer: an interim analysis of a prospective, randomized trial.
Chin J Cancer
; 34(9): 394-403, 2015 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26111932
12.
MOF@COF Nanocapsules Enhance Soft Tissue Sarcoma Treatment: Synergistic Effects of Photodynamic Therapy and PARP Inhibition on Tumor Growth Suppression and Immune Response Activation.
Adv Healthc Mater
; 13(11): e2303911, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38215731
13.
Combination of DNA ploidy, stroma, and nucleotyping predicting prognosis and tailoring adjuvant chemotherapy duration in stage III colon cancer.
Ther Adv Med Oncol
; 16: 17588359241260575, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38894737
14.
Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer.
Autophagy
; 20(1): 114-130, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37615625
15.
Efficacy and Safety of Neoadjuvant Subcutaneous Envafolimab in dMMR/MSI-H Locally Advanced Colon Cancer.
Target Oncol
; 2024 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38691294
16.
Multimodal epigenetic sequencing analysis (MESA) of cell-free DNA for non-invasive colorectal cancer detection.
Genome Med
; 16(1): 9, 2024 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38225592
17.
Long-term outcomes of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection (IOCCRC): a randomized, multicenter, prospective, phase III trial.
Int J Surg
; 2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38652147
18.
[Expression of molecular markers detected by immunohistochemistry and risk of lymph node metastasis in stage T1 and T2 colorecrectal cancers].
Zhonghua Zhong Liu Za Zhi
; 35(4): 277-81, 2013 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-23985256
19.
Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer.
Oncoimmunology
; 12(1): 2161167, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36632564
20.
A neutrophil extracellular traps-related classification predicts prognosis and response to immunotherapy in colon cancer.
Sci Rep
; 13(1): 19297, 2023 11 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37935721